[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2018/5881,2018,A1
Title: New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.
Journal: Nature chemical biology 20151101
1010814-94-4
141642-82-2
384830-13-1
1694531-32-2
2219379-72-1
1159982-66-7
371-26-6 | Ethyl 4,4,4-trifluorobutanoate | AA003Q6L | MFCD00041398
7598-91-6 | Ethyl 5-hydroxy-2-methyl-1h-indole-3-carboxylate | AA003Q9X | MFCD00044575
3938-96-3 | Ethyl methoxyacetate | AA003QD0 | MFCD00009176
76272-41-8 | Exo-3-amino-9-methyl-9-azabicyclo[3,3,1]nonane | AA003QHP | MFCD12198832
1081-15-8 | FORMALDEHYDE 2,4-DINITROPHENYLHYDRAZONE | AA003QLS | MFCD00191364
74807-44-6 | Glycyl-d-threonine dihydrate | AA003QQ1 | MFCD00067443
60-25-3 | Hexamethonium chloride dihydrate | AA003QTS | MFCD00031563
626-62-0 | Iodocyclohexane, stab. with copper | AA003QXY | MFCD00003826
400-38-4 | Isopropyl trifluoroacetate | AA003R2G | MFCD00013566
476-60-8 | Anthracene-1,4,9,10-tetraol | AA003R72 | MFCD00058948